Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

BACKGROUND: Data regarding CD4+ recovery after switching from protease inhibitor (PI)-based regimens to regimens not containing PI are scarce. METHODS: Subjects with virological success on first-PI-regimens who switched to NNRTI therapy (NNRTI group) or to nucleoside reverse transcriptase (NRTI)-onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Torti, Carlo, d'Arminio-Monforte, Antonella, Pozniak, Anton L, Lapadula, Giuseppe, Cologni, Giuliana, Antinori, Andrea, De Luca, Andrea, Mussini, Cristina, Castagna, Antonella, Cicconi, Paola, Minoli, Lorenzo, Costantini, Andrea, Carosi, Giampiero, Liang, Hua, Cesana, Bruno M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038912/
https://www.ncbi.nlm.nih.gov/pubmed/21266068
http://dx.doi.org/10.1186/1471-2334-11-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038912/
https://www.ncbi.nlm.nih.gov/pubmed/21266068
http://dx.doi.org/10.1186/1471-2334-11-23

Ejemplares similares